- Home
- GSAT vs KYMR Comparison
GSAT vs KYMR Comparison
Compare GSAT & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSAT
- KYMR
- Stock Information
- Founded
- GSAT 2003
- KYMR 2015
- Country
- GSAT United States
- KYMR United States
- Employees
- GSAT N/A
- KYMR N/A
- Industry
- GSAT Telecommunications Equipment
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- GSAT Consumer Discretionary
- KYMR Health Care
- Exchange
- GSAT Nasdaq
- KYMR Nasdaq
- Market Cap
- GSAT 2.7B
- KYMR 3.1B
- IPO Year
- GSAT 2006
- KYMR 2020
- Fundamental
- Price
- GSAT $27.15
- KYMR $44.64
- Analyst Decision
- GSAT Strong Buy
- KYMR Strong Buy
- Analyst Count
- GSAT 3
- KYMR 16
- Target Price
- GSAT $43.33
- KYMR $58.94
- AVG Volume (30 Days)
- GSAT 668.5K
- KYMR 865.2K
- Earning Date
- GSAT 08-07-2025
- KYMR 08-06-2025
- Dividend Yield
- GSAT N/A
- KYMR N/A
- EPS Growth
- GSAT N/A
- KYMR N/A
- EPS
- GSAT N/A
- KYMR N/A
- Revenue
- GSAT $253,901,000.00
- KYMR $58,885,000.00
- Revenue This Year
- GSAT $7.69
- KYMR $58.26
- Revenue Next Year
- GSAT $21.67
- KYMR N/A
- P/E Ratio
- GSAT N/A
- KYMR N/A
- Revenue Growth
- GSAT 14.55
- KYMR N/A
- 52 Week Low
- GSAT $15.00
- KYMR $19.45
- 52 Week High
- GSAT $41.10
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- GSAT 79.34
- KYMR 55.84
- Support Level
- GSAT $26.53
- KYMR $43.56
- Resistance Level
- GSAT $27.65
- KYMR $46.34
- Average True Range (ATR)
- GSAT 0.92
- KYMR 1.81
- MACD
- GSAT 0.28
- KYMR -0.60
- Stochastic Oscillator
- GSAT 89.69
- KYMR 36.21
About GSAT Globalstar Inc.
Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services are typically used by customers where existing terrestrial wireline and wireless communications networks are impaired or do not exist. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is an owner of satellite assets. It has one reportable segment: MSS business. The company generates the vast majority of its revenue within the United States.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.